In the last trading session, 1.18 million Neumora Therapeutics Inc (NASDAQ:NMRA) shares changed hands as the company’s beta touched 2.62. With the company’s per share price at $0.70 changed hands at $0.03 or 5.38% during last session, the market valuation stood at $113.48M. NMRA’s last price was a discount, traded about -2355.71% off its 52-week high of $17.19. The share price had its 52-week low at $0.61, which suggests the last value was 12.86% up since then.
Analysts gave the Neumora Therapeutics Inc (NMRA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 2.25. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended NMRA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Neumora Therapeutics Inc (NASDAQ:NMRA) trade information
Instantly NMRA was in green as seen at the end of in last trading. With action 5.84%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -93.38%, with the 5-day performance at 5.84% in the green. However, in the 30-day time frame, Neumora Therapeutics Inc (NASDAQ:NMRA) is 11.37% up.
The consensus price target for the stock as assigned by Wall Street analysts is 3, meaning bulls need an upside of 76.67% from its current market value. According to analyst projections, NMRA’s forecast low is 2 with 4 as the target high. To hit the forecast high, the stock’s price needs a -471.43% plunge from its current level, while the stock would need to soar -185.71% for it to hit the projected low.
The 2025 estimates are for Neumora Therapeutics Inc earnings to increase by 7.11%, but the outlook for the next 5-year period is at 13.24% per year.
NMRA Dividends
Neumora Therapeutics Inc is expected to release its next quarterly earnings report in June.
SOFTBANK GROUP CORP. holds the second largest percentage of outstanding shares, with 4.8099% or 7.65 million shares worth $75.17 million as of 2024-06-30.
Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . With 2.32 shares estimated at $1.63 million under it, the former controlled 1.44% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 1.36% of the shares, roughly 2.21 shares worth around $1.55 million.
